Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628000 · ClinicalTrials.gov registry record
Baseline Vitamin D Deficiency and COVID-19 Disease Severity
A clinical trial of Covid19 and Vitamin D Deficiency, sponsored by Parkview Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT04628000 is a study of Covid19 and Vitamin D Deficiency that has completed, run by Parkview Medical Center. The registered enrollment target is 50 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04628000, a study of Covid19 and Vitamin D Deficiency, has completed, sponsored by Parkview Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
It is known that vitamin D has been found to decrease incidence of viral respiratory infections, as well as have effects on multiple cytokines involved in immunomodulation and the bradykinin/renin-angiotensin system. Recently, data was released showing a correlation between baseline vitamin D deficiency status and increased risk of contracting COVID-19. Separate analysis shows that many of the deleterious effects of COVID-19 may be due to the bradykinin/RAS system, and that vitamin D is one plausible treatment option to modulate these effects. Studies are currently ongoing to determine if vitamin D supplementation of those hospitalized with COVID-19 has a beneficial effect on patient outcomes. Healthcare resources have been strained during the pandemic in areas of heavy caseload. It is possible that those with concurrent vitamin D deficiency and COVID positivity have an increased need for escalation of care. A small study has been conducted in this area, but was limited by small number of subjects.
Conditions Studied
Interventions
- OTHER Vitamin D
Study Locations (1)
Colorado
- Parkview Medical Center - Pueblo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-10-27 |
| Est. Completion | 2022-04-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04628000
The ClinicalTrials.gov registry entry for NCT04628000 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (98% lower). The listed sponsor is Parkview Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D is the first listed.
NCT04628000 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04628000 about?
NCT04628000 is a clinical study titled "Baseline Vitamin D Deficiency and COVID-19 Disease Severity". It is known that vitamin D has been found to decrease incidence of viral respiratory infections, as well as have effects on multiple cytokines involved in immunomodulation and the bradykinin/renin-angiotensin system. Recently, data was released showing a correlation between baseline vitamin D defic...
What is the current status of trial NCT04628000?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2020-10-27. Estimated completion is 2022-04-14.
What conditions does trial NCT04628000 study?
This clinical trial studies the following conditions: Covid19, Vitamin D Deficiency.
What interventions are being tested in trial NCT04628000?
The interventions under investigation include: Vitamin D (OTHER).
Who is sponsoring clinical trial NCT04628000?
This trial is sponsored by Parkview Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04628000 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.